Tubeimoside I ameliorates cerebral ischemia/reperfusion injury through activating SIRT3

Main Article Content

Shaoyue Huang
Zhen Hong
Kuo Li


cerebral ischemia-reperfusion (CIR), Tubeimoside I, inflammation, apoptosis, SIRT3


Cerebral ischemia-reperfusion (CIR) seriously affects human health and life as it is accompanied by inflammation and apoptosis in brain tissues. Tubeimoside I (TBMS-1) can inhibit neuroinflammation and has neuroprotective effects; however, its effects on ischemia-reperfusion (IR) injury of the brain requires clarity. A mouse cerebral artery occlusion/reperfusion model was used to simulate CIR injury. The neurological function and the area of cerebral infarction were assessed by 2,3,5-triphenyltetrazolium chloride staining. Tumor necrosis factor-α, Interleukin (IL)-1β, IL-6, and IL-10 levels were measured by enzyme-linked-immunosorbent serologic assay kits. Protein blot analysis was performed to assess the expression of apoptosis-related factors. In addition, PC12 (pheochromocytoma) cells were treated with oxygen–glucose deprivation/reoxygenation (OGD/R) to establish an in vitro model of CIR injury. The cell viability was measured by cell counting kit-8 assay, and apoptosis levels were detected by flow cytometry. In vivo results indicated that Tubeimoside I reduced cerebral infarct size, decreased inflammatory factor content, inhibited the expression of apoptosis-related factors, including Bax and cleaved-caspase-3 (Asp175), and promoted the expression of survival factor, such as B-cell lymphoma protein 2. In vitro, Tubeimoside I was able to increase cell viability and inhibit apoptosis. Mechanistically, Tubeimoside I was able to enhance both in vivo and in vitro expressions of NAD-dependent deacetylase sirtuin-3 (SIRT3). SIRT3 inhibitor abolished the protective effect of Tubeimoside I on OGD/R-treated cells. Tubeimoside I lessened CIR injury by activating SIRT3. Hence, it could be a potential drug candidate for treating IR injury of the brain.

Abstract 169 | PDF Downloads 296 HTML Downloads 28 XML Downloads 1


Du, J., Dong, Z., Tan, L., Tan, M., Zhang, F., Zhang, K., et al., 2020. Tubeimoside I inhibits cell proliferation and induces a partly disrupted and cytoprotective autophagy through rapidly hyperactivation of MEK1/2-ERK1/2 cascade via promoting PTP1B in melanoma. Frontiers in Cell and Developmental Biology 8: 607757. 10.3389/fcell.2020.607757

He, D., Huang, B., Fu, S., Li, Y., Ran, X., Liu, Y., et al. 2018. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson’s Disease in Rats. International Journal of Molecular Science 19(8): 2242. 10.3390/ijms19082242

Hu, G.Q., Du, X., Li, Y.J., Gao, X.Q., Chen, B.Q. and Yu, L., 2017. Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway. Neural Regeneration Research 12: 96–102. 10.4103/1673-5374.198992

Liu, J., Chen, Q., Jian, Z., Xiong, X., Shao, L., Jin, T., et al. 2016. Daphnetin Protects against Cerebral Ischemia/Reperfusion Injury in Mice via Inhibition of TLR4/NF-κB Signaling Pathway. BioMed Research International 2016: 2816056. 10.1155/2016/2816056

Liu, W., Miao, Y., Zhang, L., Xu, X. and Luan, Q., 2020. MiR-211 protects cerebral ischemia/reperfusion injury by inhibiting cell apoptosis. Bioengineered 11: 189–200. 10.1080/21655979.2020.1729322

Liu, Z., Zhou, L., Ma, X., Sun, S., Qiu, H., Li, H., et al. 2018. Inhibitory effects of tubeimoside I on synoviocytes and collagen-induced arthritis in rats. Journal of Cellular Physiology 233: 8740–8753. 10.1002/jcp.26754

Lv, D., Luo, M., Cheng, Z., Wang, R., Yang, X., Guo, Y., et al. 2021. Tubeimoside I ameliorates myocardial ischemia-reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis. Oxidative Medicine and Cellular Longevity 2021: 5577019. 10.1155/2021/5577019

Novgorodov, S.A., Riley, C.L., Keffler, J.A., Yu, J., Kindy, M.S., Macklin, W.B., et al. 2016. SIRT3 deacetylates ceramide synthases: Implications for mitochondrial dysfunction and brain injury. Journal of Biological Chemistry 291: 1957–1973. 10.1074/jbc.M115.668228

Pan, B., Sun, J., Liu, Z., Wang, L., Huo, H., Zhao, Y., et al. 2021. Longxuetongluo capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms. Journal of Advanced Research 33: 215–225. 10.1016/j.jare.2021.01.016

Petrovic-Djergovic, D., Goonewardena, S.N. and Pinsky, D.J., 2016. Inflammatory disequilibrium in stroke. Circulation Research 119: 142-158. 10.1161/circresaha.116.308022

Wu, Q., Sun, G., Yuan, X., Soromou, L.W., Chen, N., Xiong, Y., et al. 2013. Tubeimoside-1 attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models. Immunopharmacology and Immunotoxicology 35: 514–523. 10.3109/08923973.2013.810643

Yang, X., Gong, F., Cai, S. and Yuan, J., 2022. Overexpression of HIC1 plays a protective effect on renal cell injury caused by lipopolysaccharide by inhibiting IL-6/STAT3 pathway. Signa Vitae 18: 147–453.

Yang, X., Li, X., Luo, M., Li, C., Huang, L., Li, X., et al. 2021a. Tubeimoside I improves endothelial function in sepsis via activation of SIRT3. Laboratory Investigation 101: 897–907. 10.1038/s41374-021-00580-y

Yang, B., Zang, L., Cui, J. and Wei, L., 2021b. Circular RNA TTC3 regulates cerebral ischemia-reperfusion injury and neural stem cells by miR-372-3p/TLR4 axis in cerebral infarction. Stem Cell Research & Therapy 12: 125. 10.1186/s13287-021-02187-y

Yao, D., Zhang, S., Hu, Z., Luo, H., Mao, C., Fan, Y., et al. 2021. CHIP ameliorates cerebral ischemia-reperfusion injury by attenuating necroptosis and inflammation. Aging (Albany NY) 13: 25564–25577. 10.18632/aging.203774

Zeng, X., Zhang, Y.D., Ma, R.Y., Chen, Y.J., Xiang, X.M., Hou, D.Y., et al. 2022. Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis. Military Medical Research 9: 25. 10.1186/s40779-022-00383-2

Zhang, Y., Zhang, Y., Jin, X.F., Zhou, X.H., Dong, X.H., Yu, W.T., et al. 2019. The role of astragaloside IV against cerebral ischemia/reperfusion injury: Suppression of apoptosis via promotion of P62-LC3-autophagy. Molecules 24(9): 1838. 10.3390/molecules24091838

Zhang, J.B., Zhang, L., Li, S.Q., Hou, A.H., Liu, W.C. and Dai, L.L., 2018. Tubeimoside I attenuates inflammation and oxidative damage in a mice model of PM(2.5)-induced pulmonary injury. Experimental and Therapeutic Medicine 15: 1602–1607. 10.3892/etm.2017.5597

Zhao, H., Luo, Y., Chen, L., Zhang, Z., Shen, C., Li, Y., et al. 2018. Sirt3 inhibits cerebral ischemia-reperfusion injury through normalizing Wnt/β-catenin pathway and blocking mitochondrial fission. Cell Stress Chaperones 23: 1079–1092. 10.1007/s12192-018-0917-y

Zhao, J., Piao, X., Wu, Y., Liang, S., Han, F., Liang, Q., et al., 2020. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling. Biomedicine & Pharmacotherapy 127: 110151. 10.1016/j.biopha.2020.110151